All 1 Debates between Bill Esterson and Emily Thornberry

Mon 20th Jul 2020
Trade Bill
Commons Chamber

Report stage & 3rd reading & 3rd reading: House of Commons & Report stage & Report stage: House of Commons & Report stage & 3rd reading

Trade Bill

Debate between Bill Esterson and Emily Thornberry
Report stage & 3rd reading & 3rd reading: House of Commons & Report stage: House of Commons
Monday 20th July 2020

(4 years, 4 months ago)

Commons Chamber
Read Full debate Trade Bill 2019-21 View all Trade Bill 2019-21 Debates Read Hansard Text Read Debate Ministerial Extracts Amendment Paper: Consideration of Bill Amendments as at 20 July 2020 - (20 Jul 2020)
Jonathan Gullis Portrait Jonathan Gullis
- Hansard - - - Excerpts

Will the hon. Gentleman give way on the scrutiny point?

Bill Esterson Portrait Bill Esterson
- Hansard - -

I do not know if Michael Spicer is talking to the hon. Gentleman or not; we will find out in a moment.

--- Later in debate ---
Bill Esterson Portrait Bill Esterson
- Hansard - -

Absolutely. We compare very badly with the scrutiny in the United States, some of which I have already described. My hon. Friend is right to make the comparison. Is it not ironic that we are in the middle of trade talks with the United States, where they have full scrutiny and we do not? While we are stuck with CRAG, in the United States debates and votes will take place in Congress, alongside the engagement with business and the unions that I described earlier.

Let us remind ourselves that CRAG was introduced as part of our scrutiny process while we were EU members, because trade agreements were an EU competence. The process included full scrutiny in the European Parliament —scrutiny that has not been replaced by an equivalent system. The hon. Member for Brighton, Pavilion (Caroline Lucas) reminded us of her experience performing exactly that role.

The Minister wrote to MPs last week. I think he read out quite a lot of his letter in his speech. He told us last week that legislation will be debated and scrutinised by Parliament in “the usual way”. The usual way? There is no “usual way”, because the usual process only worked alongside the scrutiny carried out for us in the European Parliament. Despite what the Minister says, CRAG on its own makes no sense unless the Government wish to avoid scrutiny.

Today’s amendments to the Bill are similar to those passed in March 2019. The Minister is fond of telling us how vital it is that the Bill passes, so why did the Government not accept the amended Bill last year? It could have saved a lot of trouble.

Bill Esterson Portrait Bill Esterson
- Hansard - -

And time. What possible reason can the Government have for wanting to avoid scrutiny, and why on such important areas? Perhaps there are some clues in the topics covered by the various amendments. The threat to our NHS is right at the top of the list. Investor-state dispute settlement was a scandal that came to prominence during the TTIP negotiations. Let us look at some examples of the threat posed by ISDS. The Portuguese Government were sued using ISDS when the Lisbon metro was returned to public ownership. ISDS clauses in bilateral investment treaties are being used now to prepare a series of cases against the UK Government for pausing construction contracts during the pandemic.

ISDS is not the only issue. Standstill clauses prevent Governments from returning privatised public services to the public sector. Ratchet clauses require further services to be privatised. Then there are negative lists, which require Governments to specify exactly which services are to be exempt from privatisation, with everything else up for grabs. The Prime Minister told us he favours a social insurance system in his Daily Telegraph article, so when Ministers tell us not to worry about the NHS, it simply will not wash.

Statements alone are worthless. It is very simple: the detailed text of all agreements must include cast-iron commitments, because it is not just the Prime Minister who wants to hand over our NHS to the healthcare corporations; it is his friend the US President, and it is in the US negotiating objectives, which refer to

“full market access for US products”.

They want access to NHS medicines and more, and they are not shy about saying so.

Scrutiny matters, nowhere more so than in the protection of our NHS in international trade agreements. That is why our new clause 17 is so important. Ministers say that they want export opportunities for our farmers in the United States and Australia. Export opportunities? Really? Ministers are missing the point. Farmers have to survive first. If food imports are allowed with lower production, welfare standards and costs, farmers will struggle to stay in business. They will be undercut. As trade representative Lighthizer warned us, on issues such as agriculture

“this administration is not going to compromise.”

There is no ambiguity in Mr Lighthizer’s commitment not to compromise, is there? The idea that farmers will make up for domestic sales by exporting more is a fantasy. The magical thinking of Ministers will not stand up to scrutiny—that is, of course, if scrutiny is ever allowed.